Tradjenta- A new type 2 diabetes pills approved by FDA

A new drug manufactured by Boehringer Ingelheim and Elly Lilly, Tradjenta also known by the generic name linagliptin has been approved recently by FDA (Food and Drug Administration). The pill helps to control blood sugar in adults with type 2 diabetes, which is the most general form of the disease that affects 90-95% of the 24 million people in the US. Tradjenta tablets can be used together with